The Government Council for Drug Policy Coordination (former: National Drug Commission of the Government) is a permanent advisory, initiating, and coordinating body of the Czech Republic Government, active in the sphere of drug policy.

The Advisory Board for Drug Data Collection is a permanent body of the Government Council for Drug Policy Coordination (“CGDPC”) in charge of the solution of issues in the area of use of illegal drugs and their effects.

The Government Council for Drug Policy Coordination (the 'Council' or 'GCDPC') is a permanent body of the Government of the Czech Republic acting in the area of drug policy. Key policy documents in this field include: National Drug Policy Strategy and Action Plan for the Implementation of the National Drug Policy Strategy.

The National Drug Policy Strategy 2005-2009 is a key document of the Czech Government that updates the previous strategy in line with the latest scientific knowledge of the phenomenon of drug use, the consequences of drug use, and effective solutions to drug-related problems.

The Monitoring Centre for Drugs and Drug Addiction (National Focal Point; NFP) was established on the basis of a Czech Republic Government Decree from June 19, 2002, as a part of the Secretariat of the National Drug Commission (now: Government Council for Drug Policy Coordination ). Through the National Monitoring Centre for Drugs and Drug Addiction, the Czech Republic is involved in the European network of monitoring centers - the Reitox network.

CARDS project is a project of assistance to the Balkan countries to develop their drug information systems. Czech National Monitoring Centre for Drugs and Drug Addiction is one of the "coaches" in this project.

The Czech National Monitoring Centre for Drugs and Drug Addiction (National Focal Point; NFP) is a partner of the REITOX network that was established and supported by national governments of European Union countries with the objective to monitor the situation in the field of use of psychotropic substances, prepare documentation for evidence-based decision-making at the national and the European level, and evaluate efficiency of such actions. It was established in the 2002 within the structure of the Office of the Government of the Czech Republic – Secretariat of the Council of the Government for Drug Policy Coordination .